| Literature DB >> 31418424 |
Emma Broglia1,2, Abigail Millings2, Michael Barkham2.
Abstract
BACKGROUND: Anxiety and depression continue to be prominent experiences of students approaching their university counseling service. These services face unique challenges to ensure that they continue to offer quality support with fewer resources to a growing student population. The convenience and availability of mobile phone apps offer innovative solutions to address therapeutic challenges and expand the reach of traditional support.Entities:
Keywords: counseling; depressive symptoms; feasibility studies; generalized anxiety; mental health; mobile app; outcome measures; students; universities
Mesh:
Year: 2019 PMID: 31418424 PMCID: PMC6714497 DOI: 10.2196/14318
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1Participant flow diagram summarizing the number of clients that were recruited for the feasibility trial, were eligible, and participated at 3-month and 6-month follow-up phases. PHQ-9: Patient Health Questionnaire, 9-item; GAD-7: Generalized Anxiety Disorder, 7-item; TAU: treatment as usual.
Baseline scores on clinical measures on the Physical Health Questionnaire–9, Generalized Anxiety Disorder–7, Clinical Outcomes in Routine Evaluation Outcome Measure–10, and Counseling Center Assessment of Psychological Symptoms–Distress Index across intervention and treatment as usual groups from a feasibility trial.
| Measures | Baseline clinical scores across groups | |||||||
| Treatment as usual | Intervention | |||||||
| N | Mean (SD) | Min-Max | N | Mean (SD) | Min-Max | |||
| PHQ-9b,c | 18 | 17.58 (5.99) | 10-26 | 20 | 15.00 (4.71) | 10-24 | .14 | |
| GAD-7c,d | 18 | 13.75 (4.56) | 5-19 | 20 | 13.92 (4.27) | 7-20 | .42 | |
| CORE-10e,f | 11 | 22.64 (6.44) | 13-32 | 17 | 23.18 (5.41) | 15-34 | .55 | |
| Depression | 16 | 2.70 (0.69) | 1.31-3.54 | 20 | 2.30 (0.92) | 0.08-3.54 | .11 | |
| Generalized anxiety | 16 | 2.70 (0.85) | 1.44-4.00 | 20 | 2.26 (0.80) | 0.11-3.56 | .12 | |
| Social anxiety | 16 | 3.00 (0.59) | 1.86-3.86 | 20 | 2.53 (0.90) | 0.00-3.86 | .08 | |
| Academic distress | 16 | 2.79 (0.98) | 1.40-4.00 | 20 | 2.34 (0.93) | 0.60-3.40 | .17 | |
| Eating concerns | 16 | 1.49 (0.96) | 0.00-3.33 | 20 | 1.13 (0.82) | 0.00-2.78 | .23 | |
| Family distress | 16 | 1.11 (0.79) | 0.17-2.83 | 20 | 1.05 (0.87) | 0.00-2.83 | .55 | |
| Hostility | 16 | 1.57 (0.93) | 0.29-2.86 | 20 | 1.59 (0.95) | 0.14-3.57 | .85 | |
| Substance use | 16 | 0.77 (1.20) | 0.00-4.00 | 20 | 0.93 (0.94) | 0.00-3.50 | .13 | |
| Distress index | 16 | 2.68 (0.66) | 1.42-3.75 | 20 | 2.40 (0.82) | 0.25-3.80 | .55 | |
aP value from independent samples t test comparing treatment as usual and intervention group means.
bPHQ-9: Physical Health Questionnaire, 9-item.
cPHQ-9 and GAD-7 clinical boundaries: 0-5 = mild, 6-10 = moderate, 11-15 = moderately severe, 16-20/21 = severe.
dGAD-7: Generalized Anxiety Disorder, 7-item.
eCORE-10: Clinical Outcomes in Routine Evaluation Outcome Measure, 10-item.
fCORE-10 clinical boundaries: 0-5 = healthy, 5-10 = low, 10-15 = mild, 15-20 = moderate, 20-25 = moderately severe
gCCAPS-62: Counseling Center Assessment of Psychological Symptoms, 62-item.
hCCAPS-Distress Index clinical boundaries: 12.1 = low, 2.15 = elevated.
Figure 2Clinical change scores for CORE-10 and CCAPS subscales across therapy sessions 1 to 6 for the TAU and intervention groups of the feasibility trial. CORE-10: Clinical Outcomes in Routine Evaluation Outcome Measure, 10-item; CCAPS-62: Counseling Center Assessment of Psychological Symptoms, 62-item; TAU: treatment as usual.
Figure 3Clinical change scores for remaining CCAPS subscales across therapy sessions 1 to 6 for the TAU and intervention groups of the feasibility trial. CCAPS-62: Counseling Center Assessment of Psychological Symptoms, 62-item; TAU: treatment as usual.
Figure 4PHQ-9 and GAD-7 scores across participants from the intervention and TAU groups at 3-month and 6-month follow-up measures. PHQ-9: Patient Health Questionnaire, 9-item; GAD-7: Generalized Anxiety Disorder, 7-item; TAU: treatment as usual.
Individual treatment as usual participant scores on the Physical Health Questionnaire–9 and Generalized Anxiety Disorder–7 at baseline and 3- and 6-month follow-up measures with reliable and clinically significant improvement indicators.
| Measure across time | PHQ-9a | GAD-7b | |||||
| Baseline | 3 month FUc | 6 month FU | Baseline | 3 month FU | 6 month FU | ||
| 11 | 22 | 18 | 16d | 16 | 13 | 14 | |
| 12 | 10 | 4e | 3e | 5 | 3 | 4 | |
| 15 | 16 | 10d | 10d | 11 | 9 | 10 | |
| 17 | 13 | 6e | 5e | 10 | 1e | 3e | |
| 19 | 10 | 10 | 8 | 12 | 11 | 11 | |
| 26 | 23 | 20 | 20 | 14 | 15 | 16 | |
| 28 | 23 | 20 | 21 | 18 | 17 | 17 | |
| 31 | 25 | 10d | 14d | 19 | 13d | 15 | |
| 34 | 26 | 14d | 13d | 19 | 15 | 15 | |
| 35 | 18 | 12d | 12d | 17 | 15 | 15 | |
| 36 | 12 | 8 | 5e | 16 | 11d | 10d | |
| 41 | 13 | 7e | 6e | 8 | 4 | 4 | |
| Mean | 17.58 | 11.58 | 11.08 | 13.75 | 10.58 | 11.17 | |
| SD | 5.99 | 5.38 | 5.96 | 4.56 | 5.28 | 5.06 | |
| Minimum | 10 | 4 | 3 | 5 | 1 | 3 | |
| Maximum | 26 | 20 | 21 | 19 | 17 | 17 | |
| RIf count, n (%) | —g | 7 (58) | 9 (75) | — | 3 (25) | 2 (17) | |
| RCSIh count, n (%) | — | 3 (25) | 4 (33) | — | 1 (8) | 1 (8) | |
aPHQ-9: Physical Health Questionnaire, 9-item.
bGAD-7: Generalized Anxiety Disorder, 7-item.
cFU: follow-up.
dRI scores decreased by ≥6 points on the PHQ-9 and ≥5 points on the GAD-7.
eRCSI scores meet RI criteria and have postcounseling scores below the clinical cut-points.
fRI: reliable improvement.
gNot applicable, as RI and RCSI scores must be calculated from two data points.
hRCSI: reliable and clinically significant improvement.
Individual intervention participant scores on the Physical Health Questionnaire–9 and Generalized Anxiety Disorder–7 at baseline and 3- and 6-month follow-up measures with reliable and clinically significant improvement indicators.
| Measure across time | PHQ-9a | GAD-7b | |||||
| Baseline | 3 month FUc | 6 month FU | Baseline | 3 month FU | 6 month FU | ||
| 02 | 23 | 6d | 7d | 17 | 11e | 8e | |
| 03 | 16 | 9d | 5d | 7 | 3 | 3 | |
| 04 | 15 | 6d | 6d | 20 | 18 | 15e | |
| 05 | 12 | 10 | 8 | 18 | 11e | 9e | |
| 06 | 18 | 9d | 8d | 15 | 10e | 10e | |
| 08 | 10 | 6 | 7 | 8 | 5 | 5 | |
| 10 | 11 | 9 | 9 | 12 | 15 | 5d | |
| 13 | 12 | 7 | 5d | 13 | 8e | 7d | |
| 14 | 24 | 10e | 8d | 19 | 12e | 10d | |
| 22 | 16 | 8d | 5d | 12 | 7d | 6d | |
| 23 | 13 | 8 | 7d | 10 | 6 | 6 | |
| 27 | 10 | 8 | 6 | 16 | 12 | 10e | |
| Mean | 15.00 | 8.00 | 6.75 | 13.92 | 9.83 | 7.83 | |
| SD | 4.71 | 1.48 | 1.36 | 4.27 | 4.28 | 3.21 | |
| Minimum | 10 | 6 | 5 | 7 | 3 | 3 | |
| Maximum | 24 | 10 | 9 | 20 | 18 | 15 | |
| RIf count, n (%) | —g | 6 (50) | 8 (67) | — | 6 (50) | 9 (75) | |
| RCSIh count, n (%) | — | 5 (42) | 8 (67) | — | 1 (8) | 4 (33) | |
aPHQ-9: Physical Health Questionnaire, 9-item.
bGAD-7: Generalized Anxiety Disorder, 7-item.
cFU: month follow-up.
dRCSI scores meet RI criteria and have post-counseling scores below the clinical cut-points.
eRI scores decreased by ≥6 points on PHQ-9 and ≥5 points on GAD-7.
fRI: reliable improvement.
gNot applicable, as RI and RCSI scores must be calculated from two data points.
hRCSI: reliable and clinically significant improvement.